ML234
Product Specifications
Target
Histone Methyltransferase
Related Pathways
Chromatin/Epigenetic
Bioactivity
ML234 is a dual inhibitor targeting EZH2/LSD1, with IC50 values of 0.09 and 0.12 μM, respectively. It demonstrates strong antiproliferative effects on prostate cancer cell lines LNCAP, PC3, and 22RV1. Additionally, ML234 inhibits tumor growth in a 22RV1 xenograft mouse model, showing potential as a research agent in prostate cancer therapeutics.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0597703 1.0 µg DNA
DHDH sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
FY12784 100 µg
SRARP Antibody / Steroid receptor-associated and regulated protein
Sign In for Pricing
View Details MBS256088-01 5 µmol
beta- Nicotinamide- 1, N6- ethenoadenine dinucleotide phosphate (epsilon-NADP+)
Sign In for Pricing
View Details MBS256088-02 5x 5 µmol
beta- Nicotinamide- 1, N6- ethenoadenine dinucleotide phosphate (epsilon-NADP+)
Sign In for Pricing
View Details 